Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43a72884e25aaecffebe0942132d704f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37f4922dfb7777b019e504b885211b8e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_32f708c06c41fb465fb25325f69c73f2 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 |
filingDate |
2015-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f017d486b4c22bf61fd0aeb7fe691c2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81df0c1281a60bf243cb307fefe999af http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45221083ae274eea8bf0b81f06a9158d |
publicationDate |
2015-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2015128849-A1 |
titleOfInvention |
Inhibition of the fractalkine-receptor interaction for the treatment of atopic dermatitis |
abstract |
The invention relates to the treatment of atopic dermatitis through inhibition of the expression of fractalkine or of its receptor CX3CR1, or through inhibition of their interaction. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11279765-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019014122-A1 |
priorityDate |
2014-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |